Table 2.
Survival of adipose-derived stromal/stem cells
| Immunocompetent mice | Immunocompromised mice | |||||||
|---|---|---|---|---|---|---|---|---|
| % ERV-3 | Viable injection | Nonviable injection | Viable injection | Nonviable injection | ||||
| Spheroids | Cells | Spheroids | Cells | Spheroids | Cells | Spheroids | Cells | |
| Day 3 (n = 3) | 57.5 ± 3.9 | 55.6 ± 14.7 | 0.9 ± 0.8 | 0 | 90.6 ± 8.2 | 87.6 ± 6.8 | 0.1 ± 0.03 | 0.9 ± 0.3 |
| Day 10 (n = 3) | 7.1 ± 3.0 | 0 | 0 | 0 | 11.7 ± 0.8 | 12.1 ± 1.3 | 0 | 0 |
| Day 21 (n = 3) | 0 | 0 | 0 | 0 | 4.8 ± 0.6 | 6.3 ± 0.9 | 0 | 0 |
Percent survival of adipose-derived stromal/stem cells (% ERV-3) measured with real-time PCR. Values represent mean ± standard error of n = 3. ERV-3, endogenous retrovirus 3.